Published in Blood Weekly, September 1st, 1997
Researchers found that patients who were infected with hepatitis C virus (HCV) through blood transfusions were three times as likely to develop cirrhosis as intravenous drug users, independent of length of infection.
Francoise Roudot-Thoraval and colleagues suggested that these findings could have a significant impact on the future of HCV related disease, as blood screening results in fewer and fewer transfusion-associated transmissions ("Epidemiological Factors Affecting the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.